The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Open accessThe DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Abstract
Human fungal pathogens are attributable to a significant economic burden and mortality worldwide. Antifungal treatments, although limited in number, play a pivotal role in decreasing mortality and morbidities posed by invasive fungal infections (IFIs). However, the recent emergence of multidrug-resistant Candida auris and Candida glabrata and acquiring invasive infections due to azole-resistant C. parapsilosis, C. tropicalis, and Aspergillus spp. in azole-naïve patients pose a serious health threat considering the limited number of systemic antifungals available to treat IFIs. Although advancing for major fungal pathogens, the understanding of fungal attributes contributing to antifungal resistance is just emerging for several clinically important MDR fungal pathogens. Further complicating the matter are the distinct differences in antifungal resistance mechanisms among various fungal species in which one or more mechanisms may contribute to the resistance phenotype. In this review, we attempt to summarize the burden of antifungal resistance for selected non-albicansCandida and clinically important Aspergillus species together with their phylogenetic placement on the tree of life. Moreover, we highlight the different molecular mechanisms between antifungal tolerance and resistance, and comprehensively discuss the molecular mechanisms of antifungal resistance in a species level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Phylogenetic tree of Candida species studied in the current review, i.e., C. glabrata, C. parapsilosis, C. tropicalis, and C. auris (highlighted in blue). This tree was constructed using maximum likelihood of 11,570 core genes based on 1000 replicates. Asterikes does not serve any specific defnitions. This figure was adopted permission from Munoz et al., 2018 [20].](https://figures.cochat.ai/paper-figures/3e30acfc216a4d828861bcc55bf652a6/the-quiet-and-underappreciated-rise-of-drug-resistant-invasive-fungal-pathogens-figure-1.jpg)

![Figure 3 Pdr1p contains four domains. Numerous GOF mutations (black bars) can cause azole resistance. Adopted the permission from Ferrari et al., 2009 [98].](https://figures.cochat.ai/paper-figures/bd4edb3b814e44a689549f07abf351f4/the-quiet-and-underappreciated-rise-of-drug-resistant-invasive-fungal-pathogens-figure-3.jpg)

![Figure 5 Whole-genome sequence analysis of the US C. auris (up to 2018) isolates reveals the existence of four major clades. Isolates representing all identified clades have been recovered from the U.S. The Iranian clade is not shown in this figure. Adopted the permission from Chow et al., 2018 [201].](https://figures.cochat.ai/paper-figures/6559288ef9344e4d9a16d7f660126cfa/the-quiet-and-underappreciated-rise-of-drug-resistant-invasive-fungal-pathogens-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [112]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“C. krusei is considered inherently resistant to fluconazole yet demonstrates variable susceptibility to both voriconazole and posaconazole.62,103,112”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fluconazole resistance has been reported in up to 75% of C. glabrata isolates in single center surveys, and resistance to the echinocandins ranges from 0% to 24% in larger studies.27,111–113”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to the echinocandins has remained relatively infrequent (0–3%) despite a higher baseline susceptible MIC cutoff value compared to the other Candida spp. due to a naturally occurring polymorphism in FKS1.62,103,112,120”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to the echinocandins has remained relatively infrequent (0–3%) despite a higher baseline susceptible MIC cutoff value compared to the other Candida spp. due to a naturally occurring polymorphism in FKS1.62,103,112,120”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [112]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–246 of 246
Astvad, K. M. T., Sanglard, D., Delarze, E., Hare, R. K., & Arendrup, M. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01624-18 · Cited by 43
Hou, X., Healey, K. R., Shor, E., Kordalewska, M., Ortigosa, C. J., Paderu, P., Xiao, M., Wang, H., Zhao, Y., Lin, L.-Y., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1684209 · Cited by 43 · cited 3×
“Of note, mutations occurring outside of these HS regions can also lead to echinocandin therapeutic failure [54].”
BackgroundInfluentialSelf-citationDeng, S., Zhang, L., Ji, Y., Verweij, P. E., Tsui, C. K. M., Hagen, F., Houbraken, J. A. M. P., Meis, J. F., Abliz, P., Wang, X., et al. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.97 · Cited by 42
Khan, Z., Ahmad, S., Mokaddas, E., Meis, J. F., Joseph, L., Abdullah, A., & Vayalil, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01926-17 · Cited by 42
dos Reis, T. F., Silva, L. P., de Castro, P. A., do Carmo, R. A., Marini, M. M., da Silveira, J. F., Ferreira, B. H., Rodrigues, F. J. S., Lind, A., Rokas, A., et al. (2019) · mSphere · doi:10.1128/msphere.00416-19 · Cited by 42
Arastehfar, A., Daneshnia, F., Salehi, M., Yaşar, M., Hoşbul, T., Ilkit, M., Pan, W., Hagen, F., Arslan, N., Türk‐Dağı, H., et al. (2020) · Mycoses · doi:10.1111/myc.13104 · Cited by 42
Self-citationSTB5 Is a Negative Regulator of Azole Resistance in Candida glabrata
Noble, J. A., Tsai, H.-F., Suffis, S. D., Su, Q., Myers, T. G., & Bennett, J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01278-12 · Cited by 41
Hou, X., Xiao, M., Wang, H., Yu, S.-Y., Zhang, G., Zhao, Y., & Xu, Y.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-18 · Cited by 40
Arastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F., Yaşar, M., Arslan, N., Hoşbul, T., Ünal, N., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587278 · Cited by 40
Self-citationBader, O., Schwarz, A., Kraneveld, E. A., Tangwattanchuleeporn, M., Schmidt, P., Jacobsen, M. D., Gross, U., De Groot, P. W. J., & Weig, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052218 · Cited by 39 · cited 1×
“glabrata cultivated under non-stressful conditions [61].”
Cheng, S., Clancy, C. J., Hartman, D. J., Hao, B., & Nguyen, M. H. (2014) · Infection and Immunity · doi:10.1128/iai.00062-14 · Cited by 38
Aspergillus fumigatus Transcription Factors Involved in the Caspofungin Paradoxical Effect
Valero, C., Colabardini, A. C., Chiaratto, J., Pardeshi, L. A., de Castro, P. A., Filho, J. A. F., Silva, L. P., Rocha, M. C., Malavazi, I., Costa, J. H., et al. (2020) · mBio · doi:10.1128/mbio.00816-20 · Cited by 38
Costa-de-Oliveira, S., Marcos Miranda, I., Silva, R. M., Pinto e Silva, A., Rocha, R., Amorim, A., Gonçalves Rodrigues, A., & Pina-Vaz, C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00589-10 · Cited by 37
Papadimitriou‐Olivgeris, M., Spiliopoulou, A., Kolonitsiou, F., Bartzavali, C., Lambropoulou, A., Xaplanteri, P., Anastassiou, E. D., Marangos, M. N., Spiliopoulou, I. T., & Christofidou, M. (2018) · Infection · doi:10.1007/s15010-018-1217-2 · Cited by 37
Antifungal Susceptibility of Bloodstream Candida Isolates in Sfax Hospital: Tunisia
Sellami, A., Sellami, H., Néji, S., Makni, F., Abbes, S., Cheikhrouhou, F., Chelly, H., Bouaziz, M., Hammami, B., Jemâa, M. B., et al. (2010) · Mycopathologia · doi:10.1007/s11046-010-9388-0 · Cited by 36
Tan, J., Zhang, J., Chen, W., Sun, Y., Wan, Z., Li, R., & Liu, W. (2015) · Mycopathologia · doi:10.1007/s11046-014-9831-8 · Cited by 36
Won, E. J., Shin, J. H., Choi, M. J., Lee, W. G., Park, Y.-J., Uh, Y., Kim, S.-Y., Lee, M.-K., Kim, S. H., Shin, M. G., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118770 · Cited by 36
Biswas, C., Chen, S. C.-A., Halliday, C., Kennedy, K., Playford, E. G., Marriott, D. J., Slavin, M. A., Sorrell, T. C., & Sintchenko, V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.014 · Cited by 36
Chong, Y., Ito, Y., Kamimura, T., Shimoda, S., Miyamoto, T., Akashi, K., Yakushiji, H., & Shimono, N. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0412-9 · Cited by 35 · cited 4×
“Candida auris Candida auris was described for the first time in 2009, causing an ear infection in a Japanese patient [192].”
ResultInfluentialDimοpoulos, G., Velegraki, A., & Falagas, M. E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01368-08 · Cited by 35
Ala‐Houhala, M., Valkonen, M. M., Kolho, E., Friberg, N., & Anttila, V.-J. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1662941 · Cited by 33
Goemaere, B., Lagrou, K., Spriet, I., Hendrickx, M., & Becker, P. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00591-18 · Cited by 32
Barber, A. E., Weber, M., Kaerger, K., Linde, J., Gölz, H., Duerschmied, D., Markert, A., Guthke, R., Walther, G., & Kurzai, O. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01628-18 · Cited by 32
Fraser, M., Borman, A. M., Thorn, R. M. S., & Lawrance, L. M. (2019) · Medical Mycology · doi:10.1093/mmy/myz053 · Cited by 32
Changing epidemiology of non-albicans candidemia in Korea
Ko, J., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., Kim, S., et al. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.09.016 · Cited by 30
The Role of UPC2 Gene in Azole-Resistant Candida tropicalis
Jiang, C., Ni, Q., Dong, D., Zhang, L., Li, Z., Tian, Y., & Peng, Y. (2016) · Mycopathologia · doi:10.1007/s11046-016-0050-3 · Cited by 29
Kritikos, A., Neofytos, D., Khanna, N., Schreiber, P. W., Boggian, K., Bille, J., Schrenzel, J., Mühlethaler, K., Zbinden, R., Bruderer, T., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.05.012 · Cited by 28
Parent-Michaud, M., Dufresne, P. J., Fournier, É., Folch, B., Martineau, C., Moreira, S., Doucet, N., de Repentigny, L., & Dufresne, S. F. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz534 · Cited by 28
MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata
Bordallo-Cardona, M. Á., Agnelli, C., Gómez-Nuñez, A., Sánchez-Carrillo, C., Bouza, E., Muñoz, P., Escribano, P., & Guinea, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01876-18 · Cited by 27 · cited 3×
“This notion has been evaluated in French [136], Chinese [124], Spanish [35], and Indian [137] clinical isolates of C. glabrata, and it appears that the presence of a mutation in MSH2 is associated with the genotype but not with the acquisition of antifungal resistance.”
BackgroundUsher, J., & Haynes, K. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008259 · Cited by 27 · cited 3×
“The protein is comprised of four domains, namely, DNA‐binding domain (DBD), inhibitory domain (ID) (equivalent of a xenobiotic‐binding domain in Saccharomyces cerevisiae), middle‐homology domain (MHD), and activator domain (AD) (Figure 3) [100].”
BackgroundInfluentialScordino, F., Giuffrè, L., Barberi, G., Marino‐Merlo, F., Orlando, M. G., Giosa, D., & Romeo, O. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00679 · Cited by 26
Two echinocandin-resistant Candida glabrata FKS mutants from South Africa
Naicker, S. D., Magobo, R. E., Zulu, T. G., Maphanga, T. G., Luthuli, N., Lowman, W., & Govender, N. P. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.03.004 · Cited by 24
Alobaid, K., & Khan, Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.12.001 · Cited by 23
Xiao, M., Fan, X., Hou, X., Chen, S., Wang, H., Kong, F., Sun, Z.-Y., Chu, Y.-Z., & Xu, Y.-C. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s152785 · Cited by 22
Lackner, M., Obermair, J., Naschberger, V., Raschbichler, L.-M., Kandelbauer, C., Pallua, J. D., Metzlaff, J., Furxer, S., Lass‐Flörl, C., & Binder, U. (2019) · Virulence · doi:10.1080/21505594.2019.1614382 · Cited by 22
Self-citationUppuluri, P., & Lopez-Ribot, J. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_5 · Cited by 21
Unraveling How Candida albicans Forms Sexual Biofilms
Perry, A. M., Hernday, A. D., & Nobile, C. J. (2020) · Journal of Fungi · doi:10.3390/jof6010014 · Cited by 21
Grosset, M., Desnos‐Ollivier, M., Godet, C., Kauffmann‐Lacroix, C., & Roblot, F. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.12.004 · Cited by 20
Rapid emergence of FKS mutations in Candida glabrata isolates in a peritoneal candidiasis
Sasso, M., Roger, C., & Lachaud, L. (2017) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2017.04.004 · Cited by 20
Ceballos-Garzón, A., Amado, D., Robert, E., Parra‐Giraldo, C. M., & Pape, P. L. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz565 · Cited by 15
Epidemiology of candidemia at a tertiary Canadian hospital, 2004–2013
Remington, T. L., Isaac, A., Vickers, D., Fuller, J., & Smith, S. W. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.3.1.04 · Cited by 8
Wright, W. F., Bejou, N., Shields, R. K., Marr, K. A., McCarty, T. P., & Pappas, P. G. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00512-19 · Cited by 8
Tian, Y., Gao, N., Ni, Q., Mao, Y., Dong, D., Huang, X., Jiang, C., Li, Z., Zhang, L., Wang, X., et al. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy038 · Cited by 6
Lighting Up Mutation: a New Unbiased System for the Measurement of Microbial Mutation Rates
Boyce, K. J., & Idnurm, A. (2019) · mBio · doi:10.1128/mbio.00740-19 · Cited by 5
Kakeya, H., Shibata, W., Yamada, K., & Kaneko, Y. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz360.329 · Cited by 5
Kim, J. H., Suh, J. W., Kim, J. Y., Lee, H.-J., Kim, S. B., Sohn, J. W., & Kim, M. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz360.1562 · Cited by 3
Cited by
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467
“In pathogenic yeasts, ABC and MFS transporters are mainly overexpressed by GOF mutations in TAC1 and MRR1, respectively [19, 30, 46].”
BackgroundSelf-citationDrug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., Ilkit, M., Lass-Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 292
“Using this standard, echinocandin resistance among Candida species is ideally suited for resistance assessment, as is azole resistance among Aspergillus, as there is a strong correlation between clinical resistance, MIC and specific mutations in target genes [133].”
BackgroundInfluentialSelf-citationAn Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
“Better knowledge of these resistance mechanisms would assist in developing alternative therapeutic strategies to combat refractory mycoses [80,81].”
Arastehfar, A., Carvalho, A., Nguyen, M. H., Hedayati, M. T., Netea, M. G., Perlin, D. S., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6040211 · Cited by 272
Self-citationDaneshnia, F., de Almeida Júnior, J. N., Ilkit, M., Lombardi, L., Perry, A. M., Gao, M., Nobile, C. J., Egger, M., Perlin, D. S., Zhai, B., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00067-8 · Cited by 257
Self-citation
Metadata
- Authors
- Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S.
- Affiliations
- Hackensack Meridian Health (US)
- Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA
- Westerdijk Fungal Biodiversity Institute (NL)
- Division of Mycology, University of Çukurova, 01330 Adana, Turkey
- Life Sciences Programme, Barcelona, Supercomputing Center (BSC-CNS), Jordi Girona, 08034 Barcelona, Spain
- Corresponding author
- Arastehfar, Amir
- Perlin, David S.
- ORCID
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2020-08-18
- Volume
- 6
- Issue
- 3
- Pages
- 138
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC7557958
- OpenAlex
- W3070435984
- Semantic Scholar
- ffe1b3b580b5ee9de9aca8e5de0b85b315b7691d
- Cited by
- 145
- References
- 246
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 36 · 2023: 28 · 2022: 22 · 2021: 25 · 2020: 7
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UPCommons institutional repository (Universitat Politècnica de Catalunya) (acceptedVersion, cc-by)
- UvA-DARE (University of Amsterdam) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion, other-oa)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion, other-oa)
- Funders
- Astellas Pharma
- National Institutes of Health (AI109025)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- antifungal resistance, invasive fungal infections, Candida auris, Candida glabrata, Candida parapsilosis, Candida tropicalis, Aspergillus, multidrug resistance, azole resistance, antifungal tolerance, molecular mechanisms of resistance, non-albicans Candida, phylogenetic placement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.